Inhibition of the Nef regulatory protein of HIV-1 by a single-domain antibody

Blood

Volumn 117, Issue 13, 2011, Pages 3559-3568

  Bouchet, Jérôme ^a   Basmaciogullari, Stéphane E ^a   Chrobak, Pavel ^b   Stolp, Bettina ^c   Bouchard, Nathalie ^b   Fackler, Oliver T ^c   Chames, Patrick ^d   Jolicoeur, Paul ^b,e,f   Benichou, Serge ^a   Baty, Daniel ^d  

^a INSTITUT COCHIN   (France)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d INSERM   (France)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANTIBODY; CD4 ANTIGEN; COFILIN; NEF PROTEIN; P21 ACTIVATED KINASE 2; SINGLE DOMAIN ANTIBODY; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL MATURATION; CELL SURFACE; DOWN REGULATION; ENDOCYTOSIS; EXPRESSION VECTOR; GENE FREQUENCY; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERNALIZATION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; THYMUS; VIRION; VIRUS REPLICATION;

EID: 79953707336     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-07-296749     Document Type: Article

References (54)

1. Marasco WA, Sui J. The growth and potential of human antiviral monoclonal antibody therapeutics. Nat Biotechnol. 2007;25(12):1421-1434. (Pubitemid 350233138)
2. Mhashilkar AM, Bagley J, Chen SY, Szilvay AM, Helland DG, Marasco WA. Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies. EMBO J. 1995;14(7):1542-1551.
3. Tewari D, Goldstein SL, Notkins AL, Zhou P. cDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication. J Immunol. 1998;161(5):2642-2647. (Pubitemid 28397085)
4. Goncalves J, Silva F, Freitas-Vieira A, et al. Functional neutralization of HIV-1 Vif protein by intracellular immunization inhibits reverse transcription and viral replication. J Biol Chem. 2002;277(35):32036-32045. (Pubitemid 34969014)
5. Krichevsky A, Graessmann A, Nissim A, Piller SC, Zakai N, Loyter A. Antibody fragments selected by phage display against the nuclear localization signal of the HIV-1 Vpr protein inhibit nuclear import in permeabilized and intact cultured cells. Virology. 2003;305(1):77-92. (Pubitemid 36062814)
6. Levin R, Mhashilkar AM, Dorfman T, et al. Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17. Mol Med. 1997;3(2):96-110.
7. Levy-Mintz P, Duan L, Zhang H, et al. Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. J Virol. 1996;70(12):8821-8832. (Pubitemid 26378466)
8. Duan L, Bagasra O, Laughlin MA, Oakes JW, Pomerantz RJ. Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. Proc Natl Acad Sci U S A. 1994;91(11):5075-5079. (Pubitemid 24177795)
9. Theisen DM, Pongratz C, Wiegmann K, Rivero F, Krut O, Kronke M. Targeting of HIV-1 Tat traffic and function by transduction-competent single chain antibodies. Vaccine. 2006;24(16):3127-3136.
10. Biocca S, Ruberti F, Tafani M, Pierandrei-Amaldi P, Cattaneo A. Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria. Biotechnology (N Y). 1995;13(10):1110-1115.
11. Hamers-Casterman C, Atarhouch T, Muyldermans S, et al. Naturally occurring antibodies devoid of light chains. Nature. 1993;363(6428):446-448. (Pubitemid 23179389)
12. Dolk E, van Vliet C, Perez JM, et al. Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen. Proteins. 2005;59(3):555-564. (Pubitemid 40594299)
13. Kirchhofer A, Helma J, Schmidthals K, et al. Modulation of protein properties in living cells using nanobodies. Nat Struct Mol Biol. 2010;17(1):133-138.
14. Nguyen VK, Desmyter A, Muyldermans S. Functional heavy-chain antibodies in Camelidae. Adv Immunol. 2001;79:261-296. (Pubitemid 32977578)
15. Aires da Silva F, Santa-Marta M, Freitas-Vieira A, et al. Camelized rabbit-derived VH single-domain intrabodies against Vif strongly neutralize HIV-1 infectivity. J Mol Biol. 2004;340(3):525-542. (Pubitemid 38797998)
16. Vercruysse T, Pardon E, Vanstreels E, Steyaert J, Daelemans D. An intrabody based on a llama single-domain antibody targeting the N-terminal alpha-helical multimerization domain of HIV-1 rev prevents viral production. J Biol Chem. 2010;285(28):21768-21780.
17. Foster JL, Garcia JV. HIV-1 Nef: at the crossroads. Retrovirology. 2008;5:84.
18. Craig HM, Pandori MW, Guatelli JC. Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc Natl Acad Sci U SA. 1998;95(19):11229-11234. (Pubitemid 28450110)
19. Noviello CM, Benichou S, Guatelli JC. Cooperative binding of the class I major histocompatibility complex cytoplasmic domain and human immunodeficiency virus type 1 Nef to the endosomal AP-1 complex via its mu subunit. J Virol. 2008;82(3):1249-1258.
20. Stolp B, Reichman-Fried M, Abraham L, et al. HIV-1 Nef interferes with host cell motility by deregulation of Cofilin. Cell Host Microbe. 2009;6(2):174-186.
21. Fackler OT, Alcover A, Schwartz O. Modulation of the immunological synapse: a key to HIV-1 pathogenesis? Nat Rev Immunol. 2007;7(4):310-317.
22. Rudolph JM, Eickel N, Haller C, Schindler M, Fackler OT. Inhibition of T-cell receptor-induced actin remodeling and relocalization of Lck are evolutionarily conserved activities of lentiviral Nef proteins. J Virol. 2009;83(22):11528-11539.
23. Haller C, Rauch S, Michel N, et al. The HIV-1 pathogenicity factor Nef interferes with maturation of stimulatory T-lymphocyte contacts by modulation of N-Wasp activity. J Biol Chem. 2006;281(28):19618-19630. (Pubitemid 44035465)
24. Learmont JC, Geczy AF, Mills J, et al. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. N Engl J Med. 1999;340(22):1715-1722. (Pubitemid 29252599)
25. Kestler HW III, Ringler DJ, Mori K, et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 1991;65(4):651-662.
26. Baba TW, Liska V, Khimani AH, et al. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat Med. 1999;5(2):194-203. (Pubitemid 29068527)
27. Skowronski J, Parks D, Mariani R. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 1993;12(2):703-713. (Pubitemid 23073718)
28. Lindemann D, Wilhelm R, Renard P, Althage A, Zinkernagel R, Mous J. Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3′-long terminal repeat transgene. J Exp Med. 1994;179(3):797-807.
29. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, Jolicoeur P. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell. 1998;95(2):163-175. (Pubitemid 28473778)
30. Olszewski A, Sato K, Aron ZD, et al. Guanidine alkaloid analogs as inhibitors of HIV-1 Nef interactions with p53, actin, and p56lck. Proc Natl Acad Sci U S A. 2004;101(39):14079-14084. (Pubitemid 39305033)
31. Betzi S, Restouin A, Opi S, et al. Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein. Proc Natl Acad Sci U S A. 2007;104(49):19256-19261.
32. Hiipakka M, Huotari P, Manninen A, Renkema GH, Saksela K. Inhibition of cellular functions of HIV-1 Nef by artificial SH3 domains. Virology. 2001;286(1):152-159. (Pubitemid 32675475)
33. Emert-Sedlak L, Kodama T, Lerner EC, et al. Chemical library screens targeting an HIV-1 accessory factor/host cell kinase complex identify novel antiretroviral compounds. ACS Chem Biol. 2009;4(11):939-947.
34. Hassan R, Suzu S, Hiyoshi M, et al. Dys-regulated activation of a Src tyrosine kinase Hck at the Golgi disturbs N-glycosylation of a cytokine receptor Fms. J Cell Physiol. 2009;221(2):458-468.
35. Behar G, Chames P, Teulon I, et al. Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen. FEBS J. 2009;276(14):3881-3893.
36. Chames P, Hoogenboom HR, Henderikx P. Selection of antibodies against biotinylated antigens. Methods Mol Biol. 2002;178:147-157.
37. Burtey A, Rappoport JZ, Bouchet J, et al. Dynamic interaction of HIV-1 Nef with the clathrinmediated endocytic pathway at the plasma membrane. Traffic. 2007;8(1):61-76. (Pubitemid 44921883)
38. Rauch S, Pulkkinen K, Saksela K, Fackler OT. Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity. J Virol. 2008;82(6):2918-2929. (Pubitemid 351329181)
39. Sauter D, Schindler M, Specht A, et al. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe. 2009;6(5):409-421.
40. Casartelli N, Di Matteo G, Argentini C, et al. Structural defects and variations in the HIV-1 nef gene from rapid, slow and non-progressor children. Aids. 2003;17(9):1291-1301. (Pubitemid 36819843)
41. Mariani R, Skowronski J. CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. Proc Natl Acad Sci U S A. 1993;90(12):5549-5553. (Pubitemid 23176198)
42. Spina CA, Kwoh TJ, Chowers MY, Guatelli JC, Richman DD. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J Exp Med. 1994;179(1):115-123. (Pubitemid 24012976)
43. Laguette N, Bregnard C, Bouchet J, Benmerah A, Benichou S, Basmaciogullari S. Nef-induced CD4 endocytosis in human immunodeficiency virus type 1 host cells: role of p56lck kinase. J Virol. 2009;83(14):7117-7128.
44. Laguette N, Benichou S, Basmaciogullari S. Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity. J Virol. 2009;83(2):1093-1104.
45. Weng X, Priceputu E, Chrobak P, et al. CD4+ T cells from CD4C/HIVNef transgenic mice show enhanced activation in vivo with impaired proliferation in vitro but are dispensable for the development of a severe AIDS-like organ disease. J Virol. 2004;78(10):5244-5257. (Pubitemid 38581476)
46. Madrid R, Janvier K, Hitchin D, et al. Nef-induced alteration of the early/recycling endosomal compartment correlates with enhancement of HIV-1 infectivity. J Biol Chem. 2005;280(6):5032-5044. (Pubitemid 40288679)
47. Renkema GH, Manninen A, Mann DA, Harris M, Saksela K. Identification of the Nef-associated kinase as p21-activated kinase 2. Curr Biol. 1999; 9(23):1407-1410.
48. Stoddart CA, Geleziunas R, Ferrell S, et al. Human immunodeficiency virus type 1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis. J Virol. 2003;77(3):2124-2133. (Pubitemid 36110025)
49. Chaudhuri R, Lindwasser OW, Smith WJ, Hurley JH, Bonifacino JS. Downregulation of CD4 by human immunodeficiency virus type 1 Nef is dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin adaptor. J Virol. 2007;81(8):3877-3890. (Pubitemid 46586884)
50. Mangasarian A, Piguet V, Wang JK, Chen YL, Trono D. Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J Virol. 1999;73(3):1964-1973. (Pubitemid 29098098)
51. Piguet V, Wan L, Borel C, et al. HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nat Cell Biol. 2000;2(3):163-167.
52. Schindler M, Rajan D, Specht A, et al. Association of Nef with p21-activated kinase 2 is dispensable for efficient human immunodeficiency virus type 1 replication and cytopathicity in ex vivo-infected human lymphoid tissue. J Virol. 2007;81(23):13005-13014. (Pubitemid 350156939)
53. Pizzato M, Popova E, Gottlinger HG. Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles. J Virol. 2008;82(21):10811-10819. (Pubitemid 352691182)
54. Chrobak P, Simard MC, Bouchard N, et al. HIV-1 Nef disrupts maturation of CD4+ T cells through CD4/Lck modulation. J Immunol. Oct 1;185(7):3948-3959.